| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |